Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations

Recruiting now

Conditions studied: Cystic Fibrosis Pulmonary Exacerbation

In brief

The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).

Key facts

Study ID

NCT06546943

Run by

University of Colorado, Denver

People needed

50

Starts

2022-02-04

Expected to finish

2025-10-31

Last updated by the study team

2024-08-09

Who can join

Age: 6 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 6- 25 years old
• Confirmed diagnosis of cystic fibrosis (based on sweat chloride and/or two known disease causing CF mutations)
• access to a smart phone and/or internet connection and the ability to complete remote telehealth visits

You may not qualify if…

• known type 1 or type 2 diabetes, monogenic diabetes
• critical illness requiring admission to the ICU
• pregnancy

Where it is running

• Children's Hospital Colorado, University of Colorado Denver — Aurora, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.